Buscar resultados de ensayos clínicos
Neuromyelitis Optica Spectrum Disorder - 4 Studies Found
| Estado | Estudiar |
| NOT_YET_RECRUITING |
Nombre del estudio: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA� During Pregnancy Condición: Fecha: 2025-12-14 Intervenciones: Enrolled female participants with NMOSD who were exposed to UPLIZNA during pregnancy will be assessed.No study drug will be administered. |
| NOT_YET_RECRUITING |
Nombre del estudio: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders Condición: Fecha: 2025-12-14 Intervenciones: Inebilizumab: 300mg IV on Day1 and Day 15.The first dose of inelizumab is given during IVMP. |
| COMPLETED |
Nombre del estudio: Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Condición: Neuromyelitis Optica Spectrum Disorder Fecha: 2025-12-14 Intervenciones: IV, once every 12 weeks (Q12W) |
| COMPLETED |
Nombre del estudio: BLAZE-Limiting Approach in NMOSD Condición: Neuromyelitis Optica Spectrum Disorders (NMOSD) Fecha: 2025-12-14 Intervenciones: Eculizumab was administered intravenously at a dosage of 900 mg weekly for four consecutive weeks |